Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma
The epidermal growth factor (EGF)/EGF-receptor (ErbB1-4) family is involved in the biology of multiple myeloma (MM). In particular, ErbB-specific inhibitors induce strong apoptosis of myeloma cells (MMC) in vitro. To delineate the contribution of the 10 EGF-family ligands to the pathogenesis of MM,...
Gespeichert in:
| Hauptverfasser: | , , , , , , , , , , , , , , |
|---|---|
| Dokumenttyp: | Article (Journal) |
| Sprache: | Englisch |
| Veröffentlicht: |
29 May 2006
|
| In: |
Oncogene
Year: 2006, Jahrgang: 25, Heft: 54, Pages: 7180-7191 |
| ISSN: | 1476-5594 |
| DOI: | 10.1038/sj.onc.1209699 |
| Online-Zugang: | Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1038/sj.onc.1209699 Verlag, lizenzpflichtig, Volltext: https://www.nature.com/articles/1209699 
|
| Verfasserangaben: | K. Mahtouk, F.W. Cremer, T. Rème, M. Jourdan, M. Baudard, J. Moreaux, G. Requirand, G. Fiol, J. De Vos, M. Moos, P. Quittet, H. Goldschmidt, J.-F. Rossi, D. Hose and B. Klein |
MARC
| LEADER | 00000caa a2200000 c 4500 | ||
|---|---|---|---|
| 001 | 1789607329 | ||
| 003 | DE-627 | ||
| 005 | 20220820130848.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 220215s2006 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1038/sj.onc.1209699 |2 doi | |
| 035 | |a (DE-627)1789607329 | ||
| 035 | |a (DE-599)KXP1789607329 | ||
| 035 | |a (OCoLC)1341441770 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rda | ||
| 041 | |a eng | ||
| 084 | |a 33 |2 sdnb | ||
| 100 | 1 | |a Mahtouk, Karène |e VerfasserIn |0 (DE-588)1248947622 |0 (DE-627)1785234781 |4 aut | |
| 245 | 1 | 0 | |a Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma |c K. Mahtouk, F.W. Cremer, T. Rème, M. Jourdan, M. Baudard, J. Moreaux, G. Requirand, G. Fiol, J. De Vos, M. Moos, P. Quittet, H. Goldschmidt, J.-F. Rossi, D. Hose and B. Klein |
| 264 | 1 | |c 29 May 2006 | |
| 300 | |a 12 | ||
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a Computermedien |b c |2 rdamedia | ||
| 338 | |a Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Gesehen am 15.02.2022 | ||
| 520 | |a The epidermal growth factor (EGF)/EGF-receptor (ErbB1-4) family is involved in the biology of multiple myeloma (MM). In particular, ErbB-specific inhibitors induce strong apoptosis of myeloma cells (MMC) in vitro. To delineate the contribution of the 10 EGF-family ligands to the pathogenesis of MM, we have assessed their expression and biological activity. Comparing Affymetrix DNA-microarray-expression-profiles of CD138-purified plasma-cells from 65 MM-patients and 7 normal individuals to those of plasmablasts and B-cells, we found 5/10 EGF-family genes to be expressed in MMC. Neuregulin-2 and neuregulin-3 were expressed by MMC only, while neuregulin-1, amphiregulin and transforming growth factor-α were expressed by both MMC and normal plasma-cells. Using real-time polymerase chain reaction, we found HB-EGF, amphiregulin, neuregulin-1 and epiregulin to be expressed by cells from the bone marrow-environment. Only the EGF-members able to bind heparan-sulphate proteoglycans (HSPGs) - neuregulin-1, amphiregulin, HB-EGF - promote the growth of MMC. Those ligands strongly bind MMC through HSPGs. The binding and the MMC growth activity was abrogated by heparitinase, heparin or deletion of the HS-binding domain. The number of HS-binding EGF ligand molecules bound to MMC was higher than 105 molecules/cell and paralleled that of syndecan-1. Syndecan-1, the main HSPG present on MM cells, likely concentrates high levels of HS-binding-EGF-ligands at the cell membrane and facilitates ErbB-activation. Altogether, our data further identify EGF-signalling as promising target for MM-therapy. | ||
| 650 | 4 | |a Apoptosis | |
| 650 | 4 | |a Cell Biology | |
| 650 | 4 | |a general | |
| 650 | 4 | |a Human Genetics | |
| 650 | 4 | |a Internal Medicine | |
| 650 | 4 | |a Medicine/Public Health | |
| 650 | 4 | |a Oncology | |
| 700 | 1 | |a Cremer, Friedrich Walter |d 1967- |e VerfasserIn |0 (DE-588)115550461 |0 (DE-627)691396221 |0 (DE-576)289943752 |4 aut | |
| 700 | 1 | |a Rème, T. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Jourdan, M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Baudard, M. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Moreaux, J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Requirand, G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Fiol, G. |e VerfasserIn |4 aut | |
| 700 | 1 | |a De Vos, J. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Moos, Marion |e VerfasserIn |0 (DE-588)1243124318 |0 (DE-627)1773573187 |4 aut | |
| 700 | 1 | |a Quittet, P. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Goldschmidt, Hartmut |d 1956- |e VerfasserIn |0 (DE-588)102258023X |0 (DE-627)717003809 |0 (DE-576)365637386 |4 aut | |
| 700 | 1 | |a Rossi, J.-F. |e VerfasserIn |4 aut | |
| 700 | 1 | |a Hose, Dirk |d 1969- |e VerfasserIn |0 (DE-588)139824995 |0 (DE-627)613790308 |0 (DE-576)313431698 |4 aut | |
| 700 | 1 | |a Klein, B. |e VerfasserIn |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t Oncogene |d London : Springer Nature, 1997 |g 25(2006), 54, Seite 7180-7191 |h Online-Ressource |w (DE-627)320469964 |w (DE-600)2008404-3 |w (DE-576)096188715 |x 1476-5594 |7 nnas |a Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma |
| 773 | 1 | 8 | |g volume:25 |g year:2006 |g number:54 |g pages:7180-7191 |g extent:12 |a Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma |
| 856 | 4 | 0 | |u https://doi.org/10.1038/sj.onc.1209699 |x Verlag |x Resolving-System |z lizenzpflichtig |3 Volltext |
| 856 | 4 | 0 | |u https://www.nature.com/articles/1209699 |x Verlag |z lizenzpflichtig |3 Volltext |
| 951 | |a AR | ||
| 992 | |a 20220215 | ||
| 993 | |a Article | ||
| 994 | |a 2006 | ||
| 998 | |g 139824995 |a Hose, Dirk |m 139824995:Hose, Dirk |d 910000 |d 910100 |e 910000PH139824995 |e 910100PH139824995 |k 0/910000/ |k 1/910000/910100/ |p 14 | ||
| 998 | |g 102258023X |a Goldschmidt, Hartmut |m 102258023X:Goldschmidt, Hartmut |d 910000 |d 910100 |e 910000PG102258023X |e 910100PG102258023X |k 0/910000/ |k 1/910000/910100/ |p 12 | ||
| 998 | |g 1243124318 |a Moos, Marion |m 1243124318:Moos, Marion |d 910000 |d 910100 |e 910000PM1243124318 |e 910100PM1243124318 |k 0/910000/ |k 1/910000/910100/ |p 10 | ||
| 998 | |g 115550461 |a Cremer, Friedrich Walter |m 115550461:Cremer, Friedrich Walter |d 910000 |d 910100 |e 910000PC115550461 |e 910100PC115550461 |k 0/910000/ |k 1/910000/910100/ |p 2 | ||
| 999 | |a KXP-PPN1789607329 |e 4059926329 | ||
| BIB | |a Y | ||
| SER | |a journal | ||
| JSO | |a {"language":["eng"],"person":[{"display":"Mahtouk, Karène","family":"Mahtouk","given":"Karène","role":"aut"},{"display":"Cremer, Friedrich Walter","family":"Cremer","role":"aut","given":"Friedrich Walter"},{"role":"aut","given":"T.","display":"Rème, T.","family":"Rème"},{"role":"aut","given":"M.","family":"Jourdan","display":"Jourdan, M."},{"role":"aut","given":"M.","display":"Baudard, M.","family":"Baudard"},{"given":"J.","role":"aut","family":"Moreaux","display":"Moreaux, J."},{"display":"Requirand, G.","family":"Requirand","given":"G.","role":"aut"},{"display":"Fiol, G.","family":"Fiol","role":"aut","given":"G."},{"role":"aut","given":"J.","family":"De Vos","display":"De Vos, J."},{"family":"Moos","display":"Moos, Marion","given":"Marion","role":"aut"},{"family":"Quittet","display":"Quittet, P.","role":"aut","given":"P."},{"given":"Hartmut","role":"aut","family":"Goldschmidt","display":"Goldschmidt, Hartmut"},{"role":"aut","given":"J.-F.","display":"Rossi, J.-F.","family":"Rossi"},{"family":"Hose","display":"Hose, Dirk","given":"Dirk","role":"aut"},{"family":"Klein","display":"Klein, B.","given":"B.","role":"aut"}],"physDesc":[{"extent":"12 S."}],"name":{"displayForm":["K. Mahtouk, F.W. Cremer, T. Rème, M. Jourdan, M. Baudard, J. Moreaux, G. Requirand, G. Fiol, J. De Vos, M. Moos, P. Quittet, H. Goldschmidt, J.-F. Rossi, D. Hose and B. Klein"]},"recId":"1789607329","relHost":[{"language":["eng"],"part":{"extent":"12","volume":"25","text":"25(2006), 54, Seite 7180-7191","issue":"54","pages":"7180-7191","year":"2006"},"title":[{"title":"Oncogene","subtitle":"including Oncogene reviews","title_sort":"Oncogene"}],"pubHistory":["Nachgewiesen 14.1997 -"],"note":["Gesehen am 18.03.05"],"origin":[{"publisherPlace":"London ; Basingstoke","dateIssuedDisp":"1997-","publisher":"Springer Nature ; Nature Publ. Group","dateIssuedKey":"1997"}],"disp":"Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myelomaOncogene","type":{"media":"Online-Ressource","bibl":"periodical"},"recId":"320469964","physDesc":[{"extent":"Online-Ressource"}],"id":{"zdb":["2008404-3"],"issn":["1476-5594"],"eki":["320469964"]}}],"id":{"eki":["1789607329"],"doi":["10.1038/sj.onc.1209699"]},"title":[{"title_sort":"Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma","title":"Heparan sulphate proteoglycans are essential for the myeloma cell growth activity of EGF-family ligands in multiple myeloma"}],"note":["Gesehen am 15.02.2022"],"origin":[{"dateIssuedKey":"2006","dateIssuedDisp":"29 May 2006"}],"type":{"bibl":"article-journal","media":"Online-Ressource"}} | ||
| SRT | |a MAHTOUKKARHEPARANSUL2920 | ||